Aristotle University Of Thessaloniki (AUTH)
Φαρμακοκινητική, φαρμακοδυναμική και ανοσοτροποποιητική μελέτη της δαπτομυκίνης σε βρέφη και παιδιά
Abstract
dc:descriptionStaphylococcal infections are considered as a major etiologic factor for disease manifestation and possible death in children and adults, with subsequent increase in duration and cost of hospitalization. Within hospital units, the surface of biomedical devices offers suitable environmental conditions for the development and growth of resistant S. epidermidis and MRSA biofilms, resulting in persistant or even lethal infections. Optional treatment schemes for these infections include vancomycin that targets the bursting of the bacterial cell wall, daptomycin that disrupts the bacterial cell membrane and linezolid that inhibits bacterial protein synthesis.The first part of the present thesis is focused on the in vitro comparison of the efficacy of vancomycin, linezolid and daptomycin against S. epidermidis biofilms in neonatal and adult strains. In total, 23 S. epidermidis species have been examined (13 neonatal blood samples and 10 adult blood samples) in septic patients, and the phenotypic resistance profile of biofilms against the three antibiotics was outlined via the comparison of the median MIC values of planktonic cells and biofilms. The free particulate planktonic cells appeared to be significantly more sensitive to all three antibiotics for both age groups, whereas the corresponding profile against the E. epidermidis biofims was greatly variable. In neonatal strains, vancomycin and linezolid appeared to be equally and more effective than daptomycin against S. epidermidis biofilms. In adult strains, linezolid (median MIC value: 4 mg/L) proved to be more effective than vancomycin and daptomycin against biofilms, whereas no significant deviation between vancomycin and daptomycin efficacies has been observed. The antibiotic resistance of MRSA biofilms against daptomycin was examined via testing the efficacy of neutrophils against MRSA biofilms that were pre-incubated in post-inhibitory concentrations of daptomycin. Planktonic cells pre-incubated under the same conditions were used for the comparison with the corresponding MRSA biofilms. In the present study, the addition of neutrophils in 12 pre-incubated in daptomycin MRSA biofilms resulted in an increase in the percentage for the biofilm elimination when compared to control samples. The daptomycin MIC value for mature biofilms was 32 mg/L, whereas the corresponding value for planktonic cells was 4 mg/L. The immunomodulatory effect of daptomycin was examined on the basis of the secretion levels of 16 cytokines from monocytes that were incubated in 1 or 8 mg/L of daptomycin. According to the experimental results of the present study, the incubation of monocytes in daptomycin caused increased secretion of IL-8 and TNF-α when compared to monocytes stimulated by MRSA biofilms. The IFN-γ was increased following the incubation of monocytes in 8 mg/L of daptomycin, whereas similar secretion levels for IL-1β, IL-10, IL-12 and IL-23 were observed in all cases examined. At the second part of the present thesis the pharmacokinetics of daptomycin was studied in 4 paediatric patients in intensive care, aged 8-14 years old, who needed to receive therapeutically 10 mg/kg of daptomycin per day. The pharmacokinetic parameters defined for the 1st and the 5th day of administration included the clearance, the distribution volume, the AUC and the Cmax. The resulted values clearly indicated discriminated data when dealing with paediatric septic patients that are based on increased clearance and decreased AUC values. These findings are in accordance to the current data for adults with severe infections that were treated with daptomycin. In addition, in the present study a significant increase in the AUC values were observed for the fifth day of administration in comparison to the first day, a finding that is related to the corresponging decrease in clearance and that it is probably due to the alteration of patients' hemodynamics at the stage of recovery. Further clinical studies are required in order to clarify whether the administration of higher doses of daptomycin is a prerequisite for effective treatment of children with sepsis.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2023
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kadiltzoglou, Paschalis
- Καδιλτζόγλου, Πασχάλης
Subjects
dc:subject × 18- Δαπτομυκίνη
- Βιοϋμένιο
- Φαρμακοκινητική
- Φαρμακοδυναμική
- Daptomycin
- Biofilm
- FARMACOKINETICS
- Farmacodynamics
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Παιδιατρική, Νεογνολογία και Υγεία του παιδιού
- Επιστήμες Υγείας
- Λοιμώδη νοσήματα
- Clinical Medicine
- Medical and Health Sciences
- Pediatrics, Perinatology and Child Health
- Health Sciences
- Infectious Diseases
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/53642